<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35732742</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>606</Volume><Issue>7916</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4.</ArticleTitle><Pagination><StartPage>945</StartPage><EndPage>952</EndPage><MedlinePgn>945-952</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-022-04844-5</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a heterogenous neurodegenerative disorder that affects motor neurons and voluntary muscle control<sup>1</sup>. ALS heterogeneity includes the age of manifestation, the rate of progression and the anatomical sites of symptom onset. Disease-causing mutations in specific genes have been identified and define different subtypes of ALS<sup>1</sup>. Although several ALS-associated genes have been shown to affect immune functions<sup>2</sup>, whether specific immune features account for ALS heterogeneity is poorly understood. Amyotrophic lateral sclerosis-4 (ALS4) is characterized by juvenile onset and slow progression<sup>3</sup>. Patients with ALS4 show motor difficulties by the time that they are in their thirties, and most of them require devices to assist with walking by their fifties. ALS4 is caused by mutations in the senataxin gene (SETX). Here, using Setx knock-in mice that carry the ALS4-causative L389S mutation, we describe an immunological signature that consists of clonally expanded, terminally differentiated effector memory (T<sub>EMRA</sub>) CD8&#x2009;T cells in the central nervous system and the blood of knock-in mice. Increased frequencies of antigen-specific CD8&#x2009;T cells in knock-in mice mirror the progression of motor neuron disease and correlate with anti-glioma immunity. Furthermore, bone marrow transplantation experiments indicate that the immune system has a key role in ALS4 neurodegeneration. In patients with ALS4, clonally expanded T<sub>EMRA</sub> CD8&#x2009;T cells circulate in the peripheral blood. Our results provide evidence of an antigen-specific CD8&#x2009;T cell response in ALS4, which could be used to unravel disease mechanisms and as a potential biomarker of disease state.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campisi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4173-4521</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. laura.campisi@mssm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chizari</LastName><ForeName>Shahab</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5659-1140</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jessica S Y</ForeName><Initials>JSY</Initials><Identifier Source="ORCID">0000-0003-2234-2602</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gromova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Frederick J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0003-1927-264X</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosca</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Xueyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fstkchyan</LastName><ForeName>Yesai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beharry</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Forn</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Alc&#xe1;zar</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Seve Ballesteros Foundation Brain Tumor Group, Molecular Oncology Program, Spanish National Cancer Research Centre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korobeynikov</LastName><ForeName>Vladislav A</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0002-9127-292X</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prazich</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fayad</LastName><ForeName>Zahi A</ForeName><Initials>ZA</Initials><Identifier Source="ORCID">0000-0002-3439-7347</Identifier><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seldin</LastName><ForeName>Marcus M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rubeis</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9383-6883</Identifier><AffiliationInfo><Affiliation>Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Craig L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrow</LastName><ForeName>Lyle W</ForeName><Initials>LW</Initials><Identifier Source="ORCID">0000-0001-7158-5243</Identifier><AffiliationInfo><Affiliation>Neuromuscular Division of the Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEMO Clinical Center, Fondazione Serena Onlus, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurorehabilitation Department, Istituti Clinici Scientifici Maugeri, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squatrito</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Seve Ballesteros Foundation Brain Tumor Group, Molecular Oncology Program, Spanish National Cancer Research Centre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byun</LastName><ForeName>Minji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shneider</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1103-5922</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Spada</LastName><ForeName>Albert R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marazzi</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3376-0922</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 HD075735</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS106236</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL153974</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS122140</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI150748</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI168130</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007647</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI143840</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000096</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG067581</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1017892</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R33 CA225539</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064251">Multifunctional Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C581831">SETX protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nature. 2022 Aug;608(7924):E34</RefSource><PMID Version="1">35945277</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002999" MajorTopicYN="Y">Clone Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="N">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064251" MajorTopicYN="N">Multifunctional Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests.</b> C.L. is the Scientific Director of the company NEMO LAB, and he served on a scientific advisory board for Mitsubishi Tanabe Pharma Europe, Cytokinetics, Neuraltus and Italfarmaco. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35732742</ArticleId><ArticleId IdType="mid">NIHMS1869150</ArticleId><ArticleId IdType="pmc">PMC10089623</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04844-5</ArticleId><ArticleId IdType="pii">10.1038/s41586-022-04844-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH &amp; Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med 377, 162&#x2013;172, doi:10.1056/NEJMra1603471 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME &amp; Baloh RH Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 137, 715&#x2013;730, doi:10.1007/s00401-018-1933-9 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C. et al. Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4. Ann Neurol 87, 547&#x2013;555, doi:10.1002/ana.25681 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25681</ArticleId><ArticleId IdType="pmc">PMC7818251</ArticleId><ArticleId IdType="pubmed">31957062</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389&#x2013;1392, doi:10.1126/science.1123511 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11, 251&#x2013;253, doi:10.1038/nn2047 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O. et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 122, 3063&#x2013;3087, doi:10.1172/JCI62636 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585, 96&#x2013;101, doi:10.1038/s41586-020-2625-x (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324&#x2013;1329, doi:10.1126/science.aaf1064 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A. et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep 6, 23204, doi:10.1038/srep23204 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A. et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med 8, 347ra393, doi:10.1126/scitranslmed.aaf6038 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC &amp; Collins MO TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 10, 5, doi:10.1186/s13041-017-0287-x (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y. et al. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J Exp Med 214, 1493&#x2013;1507, doi:10.1084/jem.20161524 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161524</ArticleId><ArticleId IdType="pmc">PMC5413337</ArticleId><ArticleId IdType="pubmed">28356390</ArticleId></ArticleIdList></Reference><Reference><Citation>Becherel OJ et al. Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet 9, e1003435, doi:10.1371/journal.pgen.1003435 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003435</ArticleId><ArticleId IdType="pmc">PMC3623790</ArticleId><ArticleId IdType="pubmed">23593030</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MS et al. Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis. Nat Immunol 16, 485&#x2013;494, doi:10.1038/ni.3132 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3132</ArticleId><ArticleId IdType="pmc">PMC4406851</ArticleId><ArticleId IdType="pubmed">25822250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CL et al. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients. Acta Neuropathol 136, 425&#x2013;443, doi:10.1007/s00401-018-1852-9 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1852-9</ArticleId><ArticleId IdType="pmc">PMC6098723</ArticleId><ArticleId IdType="pubmed">29725819</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathinam VA et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150, 606&#x2013;619, doi:10.1016/j.cell.2012.07.007 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.07.007</ArticleId><ArticleId IdType="pmc">PMC3660860</ArticleId><ArticleId IdType="pubmed">22819539</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CH et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell 183, 636&#x2013;649 e618, doi:10.1016/j.cell.2020.09.020 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer&#x2019;s disease. Nature 577, 399&#x2013;404, doi:10.1038/s41586-019-1895-7 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1895-7</ArticleId><ArticleId IdType="pmc">PMC7445078</ArticleId><ArticleId IdType="pubmed">31915375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D. et al. CD4(+) T cells contribute to neurodegeneration in Lewy body dementia. Science 374, 868&#x2013;874, doi:10.1126/science.abf7266 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf7266</ArticleId><ArticleId IdType="pmc">PMC9122025</ArticleId><ArticleId IdType="pubmed">34648304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindestam Arlehamn CS et al. alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson&#x2019;s disease. Nat Commun 11, 1875, doi:10.1038/s41467-020-15626-w (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15626-w</ArticleId><ArticleId IdType="pmc">PMC7171193</ArticleId><ArticleId IdType="pubmed">32313102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D. et al. T cells from patients with Parkinson&#x2019;s disease recognize alpha-synuclein peptides. Nature 546, 656&#x2013;661, doi:10.1038/nature22815 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22815</ArticleId><ArticleId IdType="pmc">PMC5626019</ArticleId><ArticleId IdType="pubmed">28636593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto M. et al. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. Annu Rev Med 69, 301&#x2013;318, doi:10.1146/annurev-med-012017-043208 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-012017-043208</ArticleId><ArticleId IdType="pubmed">29414259</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruch K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer&#x2019;s disease. Nat Med 22, 135&#x2013;137, doi:10.1038/nm.4022 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4022</ArticleId><ArticleId IdType="pubmed">26779813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenkel JM, Fraser KA &amp; Masopust D. Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs. J Immunol 192, 2961&#x2013;2964, doi:10.4049/jimmunol.1400003 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400003</ArticleId><ArticleId IdType="pmc">PMC3965619</ArticleId><ArticleId IdType="pubmed">24600038</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron JL, Madri JA, Ruddle NH, Hashim G. &amp; Janeway CA Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177, 57&#x2013;68, doi:10.1084/jem.177.1.57 (1993).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.177.1.57</ArticleId><ArticleId IdType="pmc">PMC2190872</ArticleId><ArticleId IdType="pubmed">7678116</ArticleId></ArticleIdList></Reference><Reference><Citation>Young KG, Maclean S, Dudani R, Krishnan L. &amp; Sad S. CD8+ T cells primed in the periphery provide time-bound immune-surveillance to the central nervous system. J Immunol 187, 1192&#x2013;1200, doi:10.4049/jimmunol.1100695 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100695</ArticleId><ArticleId IdType="pmc">PMC5047759</ArticleId><ArticleId IdType="pubmed">21715683</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi L. et al. Apoptosis in response to microbial infection induces autoreactive TH17 cells. Nat Immunol 17, 1084&#x2013;1092, doi:10.1038/ni.3512 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3512</ArticleId><ArticleId IdType="pmc">PMC5079524</ArticleId><ArticleId IdType="pubmed">27455420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma A, Koka R. &amp; Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24, 657&#x2013;679, doi:10.1146/annurev.immunol.24.021605.090727 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.24.021605.090727</ArticleId><ArticleId IdType="pubmed">16551262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T. et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci Immunol 5, doi:10.1126/sciimmunol.aba7918 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aba7918</ArticleId><ArticleId IdType="pubmed">32620560</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF &amp; Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 108, 1185&#x2013;1194, doi:10.1172/JCI12516 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI12516</ArticleId><ArticleId IdType="pmc">PMC209525</ArticleId><ArticleId IdType="pubmed">11602626</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt D, Goronzy JJ &amp; Weyand CM CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97, 2027&#x2013;2037, doi:10.1172/JCI118638 (1996).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118638</ArticleId><ArticleId IdType="pmc">PMC507276</ArticleId><ArticleId IdType="pubmed">8621791</ArticleId></ArticleIdList></Reference><Reference><Citation>Gearty SV et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature, doi:10.1038/s41586-021-04248-x (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04248-x</ArticleId><ArticleId IdType="pmc">PMC9315050</ArticleId><ArticleId IdType="pubmed">34847567</ArticleId></ArticleIdList></Reference><Reference><Citation>Page N. et al. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling. Nat Commun 12, 1009, doi:10.1038/s41467-021-21109-3 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21109-3</ArticleId><ArticleId IdType="pmc">PMC7881115</ArticleId><ArticleId IdType="pubmed">33579927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulken BW et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature 571, 205&#x2013;210, doi:10.1038/s41586-019-1362-5 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1362-5</ArticleId><ArticleId IdType="pmc">PMC7111535</ArticleId><ArticleId IdType="pubmed">31270459</ArticleId></ArticleIdList></Reference><Reference><Citation>Derecki NC et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207, 1067&#x2013;1080, doi:10.1084/jem.20091419 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20091419</ArticleId><ArticleId IdType="pmc">PMC2867291</ArticleId><ArticleId IdType="pubmed">20439540</ArticleId></ArticleIdList></Reference><Reference><Citation>Filiano AJ, Gadani SP &amp; Kipnis J. How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci 18, 375&#x2013;384, doi:10.1038/nrn.2017.39 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.39</ArticleId><ArticleId IdType="pmc">PMC5823005</ArticleId><ArticleId IdType="pubmed">28446786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous system. Science 353, 766&#x2013;771, doi:10.1126/science.aag2638 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2638</ArticleId><ArticleId IdType="pmc">PMC5590839</ArticleId><ArticleId IdType="pubmed">27540163</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiffelle J. et al. T-cell repertoire analysis and metrics of diversity and clonality. Curr Opin Biotechnol 65, 284&#x2013;295, doi:10.1016/j.copbio.2020.07.010 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2020.07.010</ArticleId><ArticleId IdType="pubmed">32889231</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldrini B. et al. Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling. Nat Commun 9, 1466, doi:10.1038/s41467-018-03731-w (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03731-w</ArticleId><ArticleId IdType="pmc">PMC5899147</ArticleId><ArticleId IdType="pubmed">29654229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahles A. et al. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 34, 211&#x2013;224 e216, doi:10.1016/j.ccell.2018.07.001 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2018.07.001</ArticleId><ArticleId IdType="pmc">PMC9844097</ArticleId><ArticleId IdType="pubmed">30078747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren P. et al. Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease. Front Immunol 12, 713540, doi:10.3389/fimmu.2021.713540 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.713540</ArticleId><ArticleId IdType="pmc">PMC8416054</ArticleId><ArticleId IdType="pubmed">34484216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurepa Z, Su J. &amp; Forman J. Memory phenotype of CD8+ T cells in MHC class Ia-deficient mice. J Immunol 170, 5414&#x2013;5420, doi:10.4049/jimmunol.170.11.5414 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.11.5414</ArticleId><ArticleId IdType="pubmed">12759416</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P. &amp; Shneider NA Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med 28, 104&#x2013;116, doi:10.1038/s41591-021-01615-z (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772&#x2013;1775, doi:10.1126/science.8209258 (1994).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu PH et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A 93, 3155&#x2013;3160, doi:10.1073/pnas.93.7.3155 (1996).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.7.3155</ArticleId><ArticleId IdType="pmc">PMC39778</ArticleId><ArticleId IdType="pubmed">8610185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F, Lenig D, Forster R, Lipp M. &amp; Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708&#x2013;712, doi:10.1038/44385 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/44385</ArticleId><ArticleId IdType="pubmed">10537110</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil VS et al. Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis. Sci Immunol 3, doi:10.1126/sciimmunol.aan8664 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aan8664</ArticleId><ArticleId IdType="pmc">PMC5931334</ArticleId><ArticleId IdType="pubmed">29352091</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson RO et al. Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire. Nat Genet 49, 659&#x2013;665, doi:10.1038/ng.3822 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3822</ArticleId><ArticleId IdType="pubmed">28369038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tickotsky N, Sagiv T, Prilusky J, Shifrut E. &amp; Friedman N. McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics 33, 2924&#x2013;2929, doi:10.1093/bioinformatics/btx286 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx286</ArticleId><ArticleId IdType="pubmed">28481982</ArticleId></ArticleIdList></Reference><Reference><Citation>Weekes MP, Wills MR, Mynard K, Carmichael AJ &amp; Sissons JG The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol 73, 2099&#x2013;2108, doi:10.1128/JVI.73.3.2099-2108.1999 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.3.2099-2108.1999</ArticleId><ArticleId IdType="pmc">PMC104454</ArticleId><ArticleId IdType="pubmed">9971792</ArticleId></ArticleIdList></Reference><Reference><Citation>Latorre D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63&#x2013;68, doi:10.1038/s41586-018-0540-1 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0540-1</ArticleId><ArticleId IdType="pubmed">30232458</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi L, Cummings RJ &amp; Blander JM Death-defining immune responses after apoptosis. Am J Transplant 14, 1488&#x2013;1498, doi:10.1111/ajt.12736 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.12736</ArticleId><ArticleId IdType="pmc">PMC4115279</ArticleId><ArticleId IdType="pubmed">24903539</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyand CM &amp; Goronzy JJ The immunology of rheumatoid arthritis. Nat Immunol 22, 10&#x2013;18, doi:10.1038/s41590-020-00816-x (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00816-x</ArticleId><ArticleId IdType="pmc">PMC8557973</ArticleId><ArticleId IdType="pubmed">33257900</ArticleId></ArticleIdList></Reference><Reference><Citation>Garretti F, Agalliu D, Lindestam Arlehamn CS, Sette A. &amp; Sulzer D. Autoimmunity in Parkinson&#x2019;s Disease: The Role of alpha-Synuclein-Specific T Cells. Front Immunol 10, 303, doi:10.3389/fimmu.2019.00303 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00303</ArticleId><ArticleId IdType="pmc">PMC6397885</ArticleId><ArticleId IdType="pubmed">30858851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin BA et al. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122 ( Pt 8), 1539&#x2013;1550, doi:10.1093/brain/122.8.1539 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/122.8.1539</ArticleId><ArticleId IdType="pubmed">10430837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamoreaux L, Roederer M. &amp; Koup R. Intracellular cytokine optimization and standard operating procedure. Nat Protoc 1, 1507&#x2013;1516, doi:10.1038/nprot.2006.268 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.268</ArticleId><ArticleId IdType="pubmed">17406442</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi L. In vitro Antigen-presentation Assay for Self- and Microbial-derived Antigens. Bio-protocol 7, e2307, doi:10.21769/BioProtoc.2307 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.2307</ArticleId><ArticleId IdType="pmc">PMC8410294</ArticleId><ArticleId IdType="pubmed">34541075</ArticleId></ArticleIdList></Reference><Reference><Citation>Korin B, Dubovik T. &amp; Rolls A. Mass cytometry analysis of immune cells in the brain. Nat Protoc 13, 377&#x2013;391, doi:10.1038/nprot.2017.155 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.155</ArticleId><ArticleId IdType="pubmed">29370157</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan YS &amp; Lei YL Isolation of Tumor-Infiltrating Lymphocytes by Ficoll-Paque Density Gradient Centrifugation. Methods Mol Biol 1960, 93&#x2013;99, doi:10.1007/978-1-4939-9167-9_8 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9167-9_8</ArticleId><ArticleId IdType="pmc">PMC6533618</ArticleId><ArticleId IdType="pubmed">30798524</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15&#x2013;21, doi:10.1093/bioinformatics/bts635 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK &amp; Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res 41, e108, doi:10.1093/nar/gkt214 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt214</ArticleId><ArticleId IdType="pmc">PMC3664803</ArticleId><ArticleId IdType="pubmed">23558742</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ &amp; Smyth GK edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140, doi:10.1093/bioinformatics/btp616 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47, doi:10.1093/nar/gkv007 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. 2011 17, 3, doi:10.14806/ej.17.1.200 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.14806/ej.17.1.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK &amp; Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923&#x2013;930, doi:10.1093/bioinformatics/btt656 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Law CW, Chen Y, Shi W. &amp; Smyth GK voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 15, R29, doi:10.1186/gb-2014-15-2-r29 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2014-15-2-r29</ArticleId><ArticleId IdType="pmc">PMC4053721</ArticleId><ArticleId IdType="pubmed">24485249</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y. &amp; He QY clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284&#x2013;287, doi:10.1089/omi.2011.0118 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen S. et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A 111, E5593&#x2013;5601, doi:10.1073/pnas.1419161111 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419161111</ArticleId><ArticleId IdType="pmc">PMC4280593</ArticleId><ArticleId IdType="pubmed">25480548</ArticleId></ArticleIdList></Reference><Reference><Citation>SPLINTER: Splice Interpreter Of Transcripts. version 1.4.0. (2017. ).</Citation></Reference><Reference><Citation>Hao Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587 e3529, doi:10.1016/j.cell.2021.04.048 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.048</ArticleId><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Borcherding N, Bormann NL &amp; Kraus G. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res 9, 47, doi:10.12688/f1000research.22139.2 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.22139.2</ArticleId><ArticleId IdType="pmc">PMC7400693</ArticleId><ArticleId IdType="pubmed">32789006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado-Castano S. et al. Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models. Mol Cancer Ther 14, 1247&#x2013;1258, doi:10.1158/1535-7163.MCT-14-0913 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-14-0913</ArticleId><ArticleId IdType="pmc">PMC4425597</ArticleId><ArticleId IdType="pubmed">25761895</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez NM &amp; Lynch KW Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol Rev 253, 216&#x2013;236, doi:10.1111/imr.12047 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12047</ArticleId><ArticleId IdType="pmc">PMC3621013</ArticleId><ArticleId IdType="pubmed">23550649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>